EMEA-001292-PIP01-12-M01
Key facts
| Active substance |
mifepristone
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0202/2014
|
| PIP number |
EMEA-001292-PIP01-12-M01
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Treatment of hypercortisolism (Cushing's syndrome) of endogenous origin
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Corcept Therapeutics Incorporated
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|